-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Blood -X- _ O
purification -X- _ O
is -X- _ O
an -X- _ O
emerging -X- _ O
approach -X- _ O
to -X- _ O
dampening -X- _ O
the -X- _ O
cytokine -X- _ O
storm. -X- _ O
This -X- _ O
study -X- _ O
aims -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
efficacy -X- _ O
of -X- _ O
HA330 -X- _ B-Intervention
resin-directed -X- _ I-Intervention
hemoadsorption -X- _ I-Intervention
( -X- _ I-Intervention
HA -X- _ I-Intervention
) -X- _ I-Intervention
on -X- _ O
endotoxin-induced -X- _ B-Patient
porcine -X- _ I-Patient
acute -X- _ I-Patient
respiratory -X- _ I-Patient
distress -X- _ I-Patient
syndrome -X- _ I-Patient
( -X- _ I-Patient
ARDS -X- _ I-Patient
) -X- _ I-Patient
model. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
Twenty-four -X- _ O
Chinese -X- _ B-Patient
domestic -X- _ I-Patient
pigs -X- _ I-Patient
were -X- _ O
allocated -X- _ O
into -X- _ O
saline -X- _ B-Comparison
group -X- _ I-Comparison
receiving -X- _ I-Comparison
intravenous -X- _ I-Comparison
infusion -X- _ I-Comparison
of -X- _ I-Comparison
saline -X- _ I-Comparison
( -X- _ I-Comparison
N -X- _ I-Comparison
= -X- _ I-Comparison
6 -X- _ I-Comparison
) -X- _ I-Comparison
and -X- _ O
endotoxin -X- _ O
group -X- _ O
receiving -X- _ O
intravenous -X- _ O
infusion -X- _ O
of -X- _ O
LPS -X- _ O
( -X- _ O
N -X- _ O
= -X- _ O
18 -X- _ O
) -X- _ O
. -X- _ O
When -X- _ O
ALI -X- _ O
model -X- _ O
was -X- _ O
initially -X- _ O
diagnosed -X- _ O
, -X- _ O
six -X- _ O
pigs -X- _ O
in -X- _ O
the -X- _ O
LPS -X- _ O
and -X- _ O
saline -X- _ O
group -X- _ O
were -X- _ O
killed -X- _ O
for -X- _ O
BALF -X- _ O
and -X- _ O
histopathological -X- _ O
analysis. -X- _ O
The -X- _ O
remaining -X- _ O
12 -X- _ O
pigs -X- _ O
in -X- _ O
LPS -X- _ O
group -X- _ O
received -X- _ O
3-h -X- _ O
HA -X- _ O
( -X- _ O
N -X- _ O
= -X- _ O
6 -X- _ O
) -X- _ O
or -X- _ O
HA-sham -X- _ O
( -X- _ O
N -X- _ O
= -X- _ O
6 -X- _ O
) -X- _ O
treatment -X- _ O
, -X- _ O
respectively. -X- _ O
Following -X- _ O
another -X- _ O
5-h -X- _ O
observation -X- _ O
, -X- _ O
animals -X- _ O
were -X- _ O
killed. -X- _ O
Variables -X- _ O
on -X- _ O
hemodynamics -X- _ B-Outcome
, -X- _ I-Outcome
blood -X- _ I-Outcome
gases -X- _ I-Outcome
and -X- _ I-Outcome
lung -X- _ I-Outcome
mechanics -X- _ I-Outcome
were -X- _ I-Outcome
recorded -X- _ I-Outcome
at -X- _ I-Outcome
a -X- _ I-Outcome
series -X- _ I-Outcome
of -X- _ I-Outcome
time -X- _ I-Outcome
points. -X- _ I-Outcome
Differentially -X- _ B-Outcome
expressed -X- _ I-Outcome
cytokines -X- _ I-Outcome
and -X- _ I-Outcome
proteins -X- _ I-Outcome
were -X- _ I-Outcome
determined -X- _ I-Outcome
by -X- _ I-Outcome
ELISA -X- _ I-Outcome
and -X- _ I-Outcome
proteomics. -X- _ I-Outcome
RESULTS -X- _ O
: -X- _ O
HA -X- _ O
treatment -X- _ O
significantly -X- _ O
improved -X- _ O
injured -X- _ O
oxygenation -X- _ O
induced -X- _ O
by -X- _ O
LPS. -X- _ O
HA -X- _ O
also -X- _ O
partially -X- _ O
improved -X- _ O
the -X- _ O
barrier -X- _ O
permeability -X- _ O
and -X- _ O
reduced -X- _ O
lung -X- _ O
edema -X- _ O
and -X- _ O
inflammation -X- _ O
/ -X- _ O
injury -X- _ O
induced -X- _ O
by -X- _ O
LPS -X- _ O
infusion. -X- _ O
Proteomic -X- _ O
analysis -X- _ O
showed -X- _ O
the -X- _ O
differentially -X- _ O
expressed -X- _ O
proteins -X- _ O
between -X- _ O
HA- -X- _ O
and -X- _ O
HA-sham-treated -X- _ O
groups -X- _ O
mostly -X- _ O
belonged -X- _ O
to -X- _ O
the -X- _ O
categories -X- _ O
of -X- _ O
acute -X- _ O
inflammation -X- _ O
/ -X- _ O
immune -X- _ O
response -X- _ O
, -X- _ O
and -X- _ O
proteolysis. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
Hemoadsorption -X- _ B-Outcome
improved -X- _ I-Outcome
ARDS -X- _ I-Outcome
possibly -X- _ I-Outcome
by -X- _ I-Outcome
blunting -X- _ I-Outcome
the -X- _ I-Outcome
cytokine -X- _ I-Outcome
storm -X- _ I-Outcome
and -X- _ I-Outcome
by -X- _ I-Outcome
restoring -X- _ I-Outcome
homeostasis -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
disordered -X- _ I-Outcome
proteome -X- _ I-Outcome
milieu -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
exudative -X- _ I-Outcome
phase. -X- _ I-Outcome
ELECTRONIC -X- _ O
SUPPLEMENTARY -X- _ O
MATERIAL -X- _ O
: -X- _ O
The -X- _ O
online -X- _ O
version -X- _ O
of -X- _ O
this -X- _ O
article -X- _ O
( -X- _ O
doi:10.1186 -X- _ O
/ -X- _ O
s13613-017-0287-0 -X- _ O
) -X- _ O
contains -X- _ O
supplementary -X- _ O
material -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
available -X- _ O
to -X- _ O
authorized -X- _ O
users -X- _ O
. -X- _ O

